References
- Ellenhorn M J, Barceloux D G. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. Elsevier, New York 1988
- Morgan D P, Krenzelok E P, Kulig K. Organophosphate poisoning. Poisindex® Information System, C R Gelman, B H Rumack. Micromedex, Inc., Denver, Colorado 1993, (edition expires August 31)
- Mahieu P, Hassoun A, Van Binst R, Lauwerys R, Deheneffe Y. Severe and prolonged poisoning by fenthion. Significance of the determination of the anticholinesterase capacity of plasma. J Toxicol Clin Toxicol 1982; 19: 425–432
- Brezenoff H E, Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol 1982; 22: 341–381
- LeBlanc F N, Benson B E, Gilg A D. A severe organophosphate poisoning requiring the use of an atropine drip. J Toxicol Clin Toxicol 1986; 24: 69–76
- Ludmer P L, Selwyn A P, Shook T L, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046–1051
- Vita J A, Treasure C B, Yeung A C, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85: 1390–1397
- Treasure C B, Manoukian S V, Klein J L, et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res 1992; 71: 776–781
- Katz S D, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19: 918–925
- Kullmann R, Reinsberg J, Amirmanssouri M. Regional blood flow during paraoxon infusion in rabbits. Arch Toxicol 1982; 50: 249–258
- Bataillard A, Sannajust F, Yoccoz D, et al. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats. Pharmacol Toxicol 1990; 67: 27–35
- Howland M A. Anticholinergic poisoning. Poisindex® Information System, C R Gelman, B H Rumack. Micromedex, Inc., Denver, Colorado 1993, edition expires August 31
- Hassan R M, Pesce A J, Sheng P, Hanenson I B. Correlation of serum pseudocholinesterase and clinical course in two patients poisoned with organophosphate insecticides. Clin Toxicol 1981; 18: 401–406
- Merrill D G, Mihm F G. Prolonged toxicity of organophosphate poisoning. Crit Care Med 1982; 10: 550–551
- Golsousidis H, Kokkas V. Use of 19 590 mg of atropine during 24 days of treatment, after a case of unusually severe parathion poisoning. Hum Toxicol 1985; 4: 339–340
- Davies J E, Barquet A B, Freed V H, et al. Human pesticide poisoning by fat soluble organophosphate insecticide. Arch Environ Health 1975; 30: 608–613
- Benson B, Tolo D, McIntire M. Is the intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy. J Toxicol Clin Toxicol 1992; 30: 347–349
- Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316: 761–763
- DeBleeker J, Willems J, Van Den Neucker K, DeReuck J., Vogelars D. Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. J Toxicol Clin Toxicol 1992; 30: 333–345
- de Silva H J, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?. Lancet 1992; 339: 1136–1138
- Wadia R S, Sadagopan C, Amin R B, Sardesai H V. Neurological manifestations of organophosphorus insecticide poisoning. J Neurol Neurosurg Psychiatry 1974; 37: 841–847
- Routier R J, Lipman J, Brown K. Difficulty in weaning from respiratory support in a patient with the intermediate syndrome of organophosphate poisoning. Crit Care Med 1989; 17: 1075–1076
- Karademir M, Erturk F, Kocak R. Two cases of organophosphate poisoning with development of intermediate syndrome. Hum Exp Toxicol 1990; 9: 187–189
- Karalliedde L, Senanayake N, Ariaratnam A. Acute organophosphorus insecticide poisoning during pregnancy. Hum Toxicol 1988; 7: 363–364
- Thompson D F, Thompson G D, Greenwood R B, Trammel H L. Therapeutic dosing of pralidoxime chloride. Drug Intell Clin Pharm 1987; 21: 590–593